Browse drugs

… avoid complications, including osmotic demyelination syndrome. Desmopressin can be used to prevent rapid fluctuations in sodium. While effe…

…20 monoclonal antibody that has demonstrated its superiority to rituximab (RTX) in vitro and in vivo. Our assumption is that a single inf…

…CT00661661 and ORAL Sequel) assessed time to discontinuation of tofacitinib treatment.Results At baseline, female patients had similar DAS2…

… (PST) is used to treat refractory symptoms at the end of life. Phenobarbital is infrequently used as a third-line agent following unsuccessf…

…ruption may contribute to the pathogenesis of ischaemic stroke. Minocycline was shown to exert anti-inflammatory effects by attenuating mic…

… non-concordance; with an ICU concentration of 15 mg/mL, 34% of amiodarone drug-pairs had compatibility that was concentration dependent.C…

… treatments were of very low certainty. For endoscopic relapse, vedolizumab probably reduced the risk of relapse (moderate certainty), RR 0…

…VLNC messages can be considered during the rollout of a reduced nicotine policy.Trial registration NCT05506046…

…uorouracil, cisplatin+fluorouracil and oxaliplatin+leucovorin + fluorouracil regimens were administered to 46 (67%), 4 (6%) and 19 (27%) pat…

…acting β2-agonists (LABAs), long-acting muscarinic antagonists (LAMAs) and triple therapy (ICS/LABA/LAMA), on exacerbation rates and …

… controlled trials; three observational) including 2898 LNPCPs (C-EMR 1029; H-EMR 1869) met criteria. Random-effects models produced …

…Background Janus kinase inhibitors (JAKi), like baricitinib, are used as monotherapy (MONO) and in combination with methotr…